Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 26.5B | 27.4B | 25.3B | 25.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 12.9B | 13.4B | 12.3B | 12.1B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 7.7B | 8.1B | 7.1B | 7.3B |
| Tax provision | 572M | 720M | 443M | 428M |
| Net income | 7.1B | 7.4B | 6.7B | 6.9B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 7.1B | 7.4B | 6.7B | 6.9B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |